St. Jude Medical
This article was originally published in The Gray Sheet
Physician warning issued relating to potential malfunction due to a microprocessor anomaly in "a very small number" of the firm's Trilogy family of pacemakers, firm reports March 10. Notification follows a July 1999 physician communication related to Trilogy line. Twenty out of roughly 144,000 devices currently on the market have been "reported to exhibit an inappropriate pacing mode change to single-chamber atrial pacing," the company explains. No patient injuries are reported
You may also be interested in...
"Significantly pacemaker-dependent" individuals implanted with certain Tempo and Meta pacemakers should have the devices replaced given the "potential for loss of pacing function," St. Jude Medical recommends in a June 7 physician advisory.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.